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A DNA expression library of randomly selected fra~ents of the HIV-l genome was constructed and used to search for antigenie dete~inan~. 
A large segment of the HIV-I provirus was sonicated, and lScT250 bp DNA fragments were cloned in a system of expression vectors developed 
to obtain high yields of recombinant proteins in Escherichia coil. The expressed library was immunoscreened with sera of AIDS patients. Eleven 
identified immunoreactive clones were found to correspond to already known and new antigenic regions of HIV-I proteins gp41, ~24, and reverse 
transcriptase. 
Human immu~~deficiency virus-l; Immunoepitope; Expression; Acquired immunodeficiency s ndrome; Diagnostics 
immunoreactive fragments of HIV envelope and in- 
ternal proteins are now widely used for AIDS diag- 
nostics and development of vaccine candidates [l-5]. 
Many aatigenic determinants of HIV proteins were 
identified and expressed in various systems with the use 
of recombinant DNA techniques P-51. At the same 
time, ail attempts to obtain an effective anti-HIV vac- 
cine candidate based on known antigenic determin~ts 
have been so far unsuccessful. It seems thus desirable to 
screen the whole HIV genome with the aim of revealing 
new pote~tia~y useful ~t~ge~i~ determinists. 
We developed a simple and quick method for im- 
munos~r~~~ing theviral genome based on cloning ran- 
dom fragments of viral DNA and their expression in 
Escherichia coii, An analysis of about 2000 expressed 
clones permitted us to reveal two dominant immuno- 
genic regions belonging to p24 and gp41), and also 
three minor epitopes (two in reverse transcriptase, and 
one in gp41). 
2. MATERIALS AND METHODS 
2.1. DNA library of randomly cloned fragments of the HIV-I 
genomr w 
To create the iibrary, pSP64 plasmids containing the SstI-St1 frag- 
ment of HIV-l provirus (pBHl0 isolate [61) were sonicated and a frac- 
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tion of 150-250 bp long DNA fragments was isolated. After treatment 
of the fragments with DNA polymerase I and subsequent ligation to 
an 8-mer oligonucleotide BarnHI-linker (Boehringer), they were clon- 
ed into the BarnHI site of the pVAM2 vector (see below). An E. coli 
C600 strain was used as a bacterial host for the clone library. 
2.2. Analysis of randomly cloned DNA 
Double stranded fragments of viral DNA cloned in the pVAM2 vec- 
tor were sequence essentially as described 171. CGAAGAGCATC- 
CCAAGATCGCA primer corresponding to the &-terminus of IFN-7 
was used. The nucleotide sequences were analyzed using the 
DNASTAR programs and data bank. 
2.3. The system of expression vectors 
The vectors for expression in three reading frames, pVAM1, 
pVAM2 and pVAM3 (fig.11 were co~stru~ed, each from a HindIll- 
Hpal fragment of a run-away piasmid pBEU50 (8) (containing an ori 
and /?-lactamase gene), a HindHI-PstI insert of the same plasmid- 
cont~~ng human IFN-y gene under control of pTrp*, a synthetic 
PsiI-HpaI adaptor with EcoRI and BurnHI sites in one of three possi- 
ble reading frames, and a universal transcription terminator. This set 
of vectors allows one to clone DNA fragments in three reading frames 
and to express fusion proteins composed of 1FN-y and a ~oi~eptide 
of interest at the N- and C-terminus, respectively. 
To test the vectors, a Sau3A-Sau3A fragment of gug encoding a. a. 
78-437 of the ~55 precursor (pGAG7 plasmid), and a ~g~I-~rnHI 
fragment of env encoding a. a. 466-752 of pi60 (pENV38 plasmid) 
were cloned in pVAM2 and pVAM3, respectively. The clones were ex- 
pressed in E. roll yielding recombinant immunoreactive proteins in 
amounts up to IO-lY70 of the total cell protein. They were further us- 
ed as position control. 
* The pBEU50 plasmid with the INF-7 gene insert under the control 
of pTrp was constructed at the Laboratory of Human CJene Structure 
and Function, MM. Shemyakin Institute of Bioorganic Chemistry, 
by Drs A.V. Chestukhin, K. Tikbonenko. S.A. Tsarev and S. 
Markova. A detailed description of the construction will be published 
elsewhere. 
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2.4. Immunological analysis of the library 
The transformed E. coli cells were grown on Petri dishes (Ap 50 
mg/l, Trp 10 mg/l) for 18 h at 28”C, transferred to nitrocellulose 
filters and grown under the same conditions for 2 h. The filters were 
then put on Petri dishes with agarized M9 medium (50 mg/l Ap and 
20 mg/l IAA) and grown for 4 h at 42°C. 
After the cells were lysed by chloroform treatment for 10 mitt, the 
filters were dried and preincubated for 3 h in 3% BSA, 0.05 M Na- 
phosphate buffer (pH 6.8), 0.1% Tween 20. The pretreatment was 
followed by incubation with sera taken from AIDS patients and 
diluted with E. coli C600 cell lysates, addition of protein A-peroxidase 
conjugates and staining with 4-chlorine-1-naphtol. 
Positive clones were additionally tested by ELISA on polystyrene 
plates. An overnight cell culture grown at 28°C in M9 (50 mg/l Ap, 
10 mg/l Trp) was diluted IO-fold with the same medium but without 
Trp, grown for 4 h at 28°C and then 4 h at 42°C in the presence of 
20 mg/l IAA. The cells were precipitated, resuspended in 6 M 
guanidine chloride, diluted with sodium carbonate-bicarbonate buf- 
fer, incubated for 16 h at 4°C and used in ELISA. 
3. RESULTS AND DISCUSSION 
A library of more than 2000 clones harboring DNA 
fragments about 200 bp long of the HIV-l provirus was 
immunoscreened. Fig.2 presents one of the stained 
nitrocellulose filters as an example. Clearly, the lysed 
cell clones are characterized by differential staining. 
Only heavily stained clones were found to be im- 
munoreactive in ELISA tests on plates. The ELISA 
tests were repeated with various sera that increased the 
fidelity of detecting the immunoreactive clones and 
allowed us to compare the immunoreactivity of the 
cloned regions of viral proteins. 
Eleven immunoreactive clones were revealed and 
pVAM(1,2,3) 
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Fig.1. Structure of expression vectors pVAM. The bold line refers to 
DNA of the pBEU50 plasmid; the thin line represents the fragment 
containing the IFN-7 gene, pTrp, and a synthetic oligonucleotide. 
The nucleotide sequences of the vectors are given in the lower part of 
the figure. 
Fig.2. Immunostaining of expressed clones on a nitrocellulose filter. 
characterized by this procedure (fig.3). Four clones 
(l-4) corresponded to a known gp41 immunodominant 
region (a. a. 586-m). Lysates of these clones were 
strongly immunoreactive with the majority of the sera 
used in ELISA tests. Nevertheless, there existed a 
number of sera that reacted selectively with clones 2-4 
but not with clone 1. This result supports the data that 
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Fis.3. Identified immunogenic fragments of viral proteins encoded by 
the randomly cloned provirus DNA fragments. The a. a. are 
numbered in accordance with DNASTAR data bank for the BHlO 
isolate of HIV-l. 
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Table 1 
The immunogenic regions of some HIV-l proteins, published previously and 
identified in this work 
Immunogenic region (a. a. number according to the DNASTAR data bank) 
gag W5) PO1 env (gp120) env (gp4I) 
309-376 [9]* 324-390** 504-518 (61 598-609 [4] 752-856 [7] 
329-395** 42%490** 466-548 (71 586-606 [5] 732-836 [8] 
291-355** 405-523 [8] 598~643** 752-813** 
589~665** 752-81 l** 
559-660** 752-815** 
561-635** 
* predicted 
** this work 
the region of a. a. 589-598 plays an important role in 
the functioning of one of the gp41 epitopes [1,2]. We 
also detected another gp41 immunogenic region of a. a. 
752-820 (clones 7-9). The fact that the gp41 fragments 
in all these clones begin with a. a. 752 is due to the loca- 
tion of the BarnHI site. In ELISA tests, clones 7-9 
reacted significantly weaker than clones l-4. 
The expression of two clones (5 and 6) resulted in 
recombinant proteins containing ~55 fragments which 
span the region of a. a. 291-390 and seem to include the 
main antigenic determinant of ~24. However, there 
were a number of sera which reacted in ELISA tests 
with the lysate of clone 5 only but not of clone 6, sug- 
gesting the existence of more than one epitope in this 
region. Moreover, two fairly weak immunogenic 
regions were also detected in pol (reverse transcriptase, 
clones 10 and 11). 
Table 1 ‘summarizes immunogenic regions of HIV-l 
proteins gag, pol and env both published earlier and 
found in this work. Our data on the immunogenicity of 
p24 and gp41 are in good agreement with the literature 
[ 1,2,4-61. Besides, we have managed to find two rather 
weak new immunogenic regions in pol. 
At the same time we would like to note that the 
previously described [3-51 immunogenic region close to 
the gp120 C-terminus was not spotted by screening the 
expression library. This could be explained either by the 
absence of appropriate antibodies in the sera used for 
screening or by underrepresentation of particular 
genomic fragments in the library, although the analysis 
performed is rather preliminary and not complete. The 
epitopes found by the analysis of expressed randomly 
cloned fragments of the HIV-l provirus can be used 
separately or in various combinations in AIDS diag- 
nostic kits and for construction of new vaccine can- 
didates .
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